Follow
Elias Quijano
Title
Cited by
Cited by
Year
Antisense oligonucleotides: an emerging area in drug discovery and development
K Dhuri, C Bechtold, E Quijano, H Pham, A Gupta, A Vikram, R Bahal
Journal of clinical medicine 9 (6), 2004, 2020
2932020
In vivo correction of anaemia in β-thalassemic mice by γPNA-mediated gene editing with nanoparticle delivery
R Bahal, N Ali McNeer, E Quijano, Y Liu, P Sulkowski, A Turchick, YC Lu, ...
Nature communications 7 (1), 13304, 2016
1582016
Nanoparticles that deliver triplex-forming peptide nucleic acid molecules correct F508del CFTR in airway epithelium
NA McNeer, K Anandalingam, RJ Fields, C Caputo, S Kopic, A Gupta, ...
Nature communications 6 (1), 6952, 2015
1482015
In utero nanoparticle delivery for site-specific genome editing
AS Ricciardi, R Bahal, JS Farrelly, E Quijano, AH Bianchi, VL Luks, ...
Nature communications 9 (1), 2481, 2018
1312018
Focus: genome editing: therapeutic peptide nucleic acids: principles, limitations, and opportunities
E Quijano, R Bahal, A Ricciardi, WM Saltzman, PM Glazer
The Yale journal of biology and medicine 90 (4), 583, 2017
1022017
Surface modified poly (β amino ester)-containing nanoparticles for plasmid DNA delivery
RJ Fields, CJ Cheng, E Quijano, C Weller, N Kristofik, N Duong, ...
Journal of controlled release 164 (1), 41-48, 2012
1022012
Systemic delivery of blood–brain barrier-targeted polymeric nanoparticles enhances delivery to brain tissue
JK Saucier-Sawyer, Y Deng, YE Seo, CJ Cheng, J Zhang, E Quijano, ...
Journal of drug targeting 23 (7-8), 736-749, 2015
872015
Distribution of polymer nanoparticles by convection-enhanced delivery to brain tumors
JK Saucier-Sawyer, YE Seo, A Gaudin, E Quijano, E Song, AJ Sawyer, ...
Journal of Controlled Release 232, 103-112, 2016
782016
Anti-tumor activity of miniPEG-γ-modified PNAs to inhibit microRNA-210 for cancer therapy
A Gupta, E Quijano, Y Liu, R Bahal, SE Scanlon, E Song, WC Hsieh, ...
Molecular Therapy-Nucleic Acids 9, 111-119, 2017
662017
Peptide nucleic acids as a tool for site-specific gene editing
AS Ricciardi, E Quijano, R Putman, WM Saltzman, PM Glazer
Molecules 23 (3), 632, 2018
652018
Degradable bioadhesive nanoparticles for prolonged intravaginal delivery and retention of elvitegravir
M Mohideen, E Quijano, E Song, Y Deng, G Panse, W Zhang, MR Clark, ...
Biomaterials 144, 144-154, 2017
632017
Single-stranded γPNAs for in vivo site-specific genome editing via Watson-Crick recognition
R Bahal, E Quijano, N A McNeer, Y Liu, D C Bhunia, F Lopez-Giraldez, ...
Current gene therapy 14 (5), 331-342, 2014
502014
Peptide nucleic acids and gene editing: perspectives on structure and repair
NG Economos, S Oyaghire, E Quijano, AS Ricciardi, WM Saltzman, ...
Molecules 25 (3), 735, 2020
492020
Optimizing biodegradable nanoparticle size for tissue-specific delivery
HK Mandl, E Quijano, HW Suh, E Sparago, S Oeck, M Grun, PM Glazer, ...
Journal of controlled release 314, 92-101, 2019
462019
Modified poly (lactic-co-glycolic acid) nanoparticles for enhanced cellular uptake and gene editing in the lung
RJ Fields, E Quijano, NA McNeer, C Caputo, R Bahal, K Anandalingam, ...
Advanced healthcare materials 4 (3), 361, 2015
392015
From in silico hit to long-acting late-stage preclinical candidate to combat HIV-1 infection
SN Kudalkar, J Beloor, E Quijano, KA Spasov, WG Lee, JA Cisneros, ...
Proceedings of the National Academy of Sciences 115 (4), E802-E811, 2018
342018
Direct targeting of amplified gene loci for proapoptotic anticancer therapy
M Kaushik Tiwari, DA Colon-Rios, HCR Tumu, Y Liu, E Quijano, ...
Nature Biotechnology 40 (3), 325-334, 2022
182022
Structural and pharmacological evaluation of a novel non-nucleoside reverse transcriptase inhibitor as a promising long acting nanoformulation for treating HIV
SN Kudalkar, I Ullah, N Bertoletti, HK Mandl, JA Cisneros, J Beloor, ...
Antiviral research 167, 110-116, 2019
172019
Fas ligand and nitric oxide combination to control smooth muscle growth while sparing endothelium
MH Kural, J Wang, L Gui, Y Yuan, G Li, KL Leiby, E Quijano, G Tellides, ...
Biomaterials 212, 28-38, 2019
162019
Compositions for enhancing targeted gene editing and methods of use thereof
WM Saltzman, P Glazer, R Bahal, NA McNeer, E Quijano
US Patent 11,136,597, 2021
142021
The system can't perform the operation now. Try again later.
Articles 1–20